Search Results - "Garsa, Adam A"

Predictors of Individual Tumor Local Control After Stereotactic Radiosurgery for Non-Small Cell Lung Cancer Brain Metastases by Garsa, Adam A., MD, Badiyan, Shahed N., MD, DeWees, Todd, PhD, Simpson, Joseph R., MD, PhD, Huang, Jiayi, MD, Drzymala, Robert E., PhD, Barani, Igor J., MD, Dowling, Joshua L., MD, Rich, Keith M., MD, Chicoine, Michael R., MD, Kim, Albert H., MD, PhD, Leuthardt, Eric C., MD, Robinson, Clifford G., MD

“…Purpose To evaluate local control rates and predictors of individual tumor local control for brain metastases from non-small cell lung cancer (NSCLC) treated…”
Get full text

Outcomes of Iodine-125 Plaque Brachytherapy for Uveal Melanoma With Intraoperative Ultrasonography and Supplemental Transpupillary Thermotherapy by Badiyan, Shahed N., MD, Rao, Rajesh C., MD, Apicelli, Anthony J., MD, PhD, Acharya, Sahaja, MD, Verma, Vivek, BS, Garsa, Adam A., MD, DeWees, Todd, PhD, Speirs, Christina K., MD, PhD, Garcia-Ramirez, Jose, MS, Esthappan, Jacqueline, PhD, Grigsby, Perry W., MS, MD, Harbour, J. William, MD

“…Purpose To assess the impact on local tumor control of intraoperative ultrasonographic plaque visualization and selective application of transpupillary…”
Get full text

A Prospective Longitudinal Clinical Trial Evaluating Quality of Life After Breast-Conserving Surgery and High-Dose-Rate Interstitial Brachytherapy for Early-Stage Breast Cancer by Garsa, Adam A., MD, Ferraro, Daniel J., MD, PhD, DeWees, Todd A., PhD, Deshields, Teresa L., PhD, Margenthaler, Julie A., MD, Cyr, Amy E., MD, Naughton, Michael, MD, Aft, Rebecca, MD, PhD, Gillanders, William E., MD, Eberlein, Timothy, MD, Matesa, Melissa A., BSN, RN, Ochoa, Laura L., ANP, PhD, Zoberi, Imran, MD

“…Purpose To prospectively examine quality of life (QOL) of patients with early stage breast cancer treated with accelerated partial breast irradiation (APBI)…”
Get full text

Cosmetic Analysis Following Breast-Conserving Surgery and Adjuvant High-Dose-Rate Interstitial Brachytherapy for Early-Stage Breast Cancer: A Prospective Clinical Study by Garsa, Adam A., MD, Ferraro, Daniel J., MD, PhD, DeWees, Todd, PhD, Margenthaler, Julie A., MD, Naughton, Michael, MD, Aft, Rebecca, MD, PhD, Gillanders, William E., MD, Eberlein, Timothy, MD, Matesa, Melissa A., BSN, RN, Zoberi, Imran, MD

“…Purpose To prospectively evaluate cosmetic outcomes in women treated with accelerated partial breast irradiation using high-dose-rate interstitial…”
Get full text

Management of Chordoma and Chondrosarcoma with Fractionated Stereotactic Radiotherapy by Vasudevan, Harish N, Raleigh, David R, Johnson, Julian, Garsa, Adam A, Theodosopoulos, Philip V, Aghi, Manish K, Ames, Christopher, McDermott, Michael W, Barani, Igor J, Braunstein, Steve E

“…To evaluate the efficacy and toxicity of fractionated stereotactic radiotherapy (FSRT) for chordoma and chondrosarcoma. Twenty consecutive patients with a…”
Get full text

Stereotactic body radiation therapy for the treatment of early-stage minimally invasive adenocarcinoma or adenocarcnioma in situ (formerly bronchioloalveolar carcinoma): a patterns of failure analysis by Badiyan, Shahed N, Bierhals, Andrew J, Olsen, Jeffrey R, Creach, Kimberly M, Garsa, Adam A, Dewees, Todd, Bradley, Jeffrey D, Robinson, Clifford G

“…Ongoing prospective trials exploring stereotactic body radiation therapy (SBRT) for early stage non-small cell lung cancer (NSCLC) often exclude minimally…”
Get full text

A multi‐institutional comparison of outcomes of immunosuppressed and immunocompetent patients treated with surgery and radiation therapy for cutaneous squamous cell carcinoma of the head and neck by Manyam, Bindu V., Garsa, Adam A., Chin, Re‐I, Reddy, Chandana A., Gastman, Brian, Thorstad, Wade, Yom, Sue S., Nussenbaum, Brian, Wang, Steven J., Vidimos, Allison T., Koyfman, Shlomo A.

“…BACKGROUND Patients who are chronically immunosuppressed have higher rates of cutaneous squamous cell carcinoma of the head and neck (cSCC‐HN). This is the…”
Get full text

Comparison of accelerated partial breast irradiation via multicatheter interstitial brachytherapy versus whole breast radiation by Ferraro, Daniel J, Garsa, Adam A, DeWees, Todd A, Margenthaler, Julie A, Naughton, Michael, Aft, Rebecca, Gillanders, William E, Eberlein, Timothy, Matesa, Melissa A, Zoberi, Imran

“…Brachytherapy as adjuvant treatment for early-stage breast cancer has become widely available and offers patients an expedited treatment schedule. Given this,…”
Get full text

CYP3A4 and CYP3A5 genotyping by Pyrosequencing by Garsa, Adam A, McLeod, Howard L, Marsh, Sharon

“…Human cytochrome P450 3A enzymes, particularly CYP3A4 and CYP3A5, play an important role in drug metabolism. CYP3A expression exhibits substantial…”
Get full text

Major prognostic factors for recurrence and survival independent of the American Joint Committee on Cancer eighth edition staging system in patients with cutaneous squamous cell carcinoma treated with multimodality therapy by Xu, Melody J., Lazar, Ann A., Garsa, Adam A., Arron, Sarah T., Ryan, William R., El‐Sayed, Ivan H., George, Jonathan R., Algazi, Alain P., Heaton, Chase M., Ha, Patrick K., Yom, Sue S.

“…Background The purpose of this study was to assess changes resulting from the American Joint Committee on Cancer (AJCC) eighth edition for cutaneous squamous…”
Get full text

Pretreatment metabolic tumor volume as a prognostic factor in HPV‐associated oropharyngeal cancer in the context of AJCC 8th edition staging by Floberg, John M., DeWees, Todd A., Chin, Re‐I, Garsa, Adam A., Dehdashti, Farrokh, Nussenbaum, Brian, Oppelt, Peter J., Adkins, Douglas R., Gay, Hiram A., Thorstad, Wade L.

“…Background This study evaluates the prognostic significance of 18F‐fluorodeoxyglucose‐positron emission tomography ([F‐18]FDG‐PET)‐derived metabolic tumor…”
Get full text

Dural recurrence among esthesioneuroblastoma patients presenting with intracranial extension by Yu, Yao, El‐Sayed, Ivan H., McDermott, Michael W., Theodosopoulos, Philip V., van Zante, Annemieke, Kased, Norbert, Glastonbury, Christine M., Garsa, Adam A., Yom, Sue S.

“…Objective To quantify the rate of late intracranial recurrences among esthesioneuroblastoma patients treated with surgical resection and postoperative…”
Get full text

Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer by Zhou, Margaret J., Zante, Annemieke, Lazar, Ann A., Groppo, Eli R., Garsa, Adam A., Ryan, William R., El‐Sayed, Ivan H., Eisele, David W., Yom, Sue S.

“…Background Treatment for squamous cell carcinoma (SCC) of unknown primary consists of radiotherapy (RT) +/‐ chemotherapy or neck dissection +/‐ adjuvant…”
Get full text

Prognostic value of 18F-FDG PET metabolic parameters in oropharyngeal squamous cell carcinoma by Garsa, Adam A., Chang, Albert J., DeWees, Todd, Spencer, Christopher R., Adkins, Douglas R., Dehdashti, Farrokh, Gay, Hiram A., Thorstad, Wade L.

“…Objective To evaluate whether pretreatment metabolic parameters obtained from positron emission tomography (PET) with [ 18 F]fluorodeoxyglucose (FDG) can…”
Get full text

(P053) Patterns of Failure After Multimodality Treatment of Esthesioneuroblastoma: High Risk for Meningeal Failure Among Patients With Dural Invasion at Long-Term Followup by Yu, Yao, MD, El-Sayed, Ivan H., MD, McDermott, Michael W., MD, Kased, Norbert, MD, Glastonbury, Christine M., MD, Garsa, Adam A., MD, Yom, Sue S., MD, PhD, MAS

Get full text

(P069) Prognostic Factors for Recurrence and Survival Independent of the Revised AJCC 8th Edition Staging System in Patients With Cutaneous Squamous Cell Carcinoma by Xu, Melody J, Garsa, Adam A, Lazar, Ann, Arron, Sarah T, Ryan, William R, El-Sayed, Ivan, Algazi, Alain A, George, Jonathan, Ha, Patrick, Yom, Sue S

Get full text

(P017) Management of Chordoma and Chondrosarcoma With Fractionated Stereotactic Radiotherapy by Vasudevan, Harish N., PhD, Raleigh, David R., MD, PhD, Johnson, Julian, MD, Garsa, Adam A., MD, Theodosopoulos, Philip V., MD, Aghi, Manish K., MD, PhD, Ames, Christopher, MD, McDermott, Michael W., MD, Barani, Igor J., MD, Braunstein, Steve E., MD, PhD

Get full text

(P060) Squamous Cell Carcinoma of Unknown Primary of the Head and Neck: “Low-Risk” Prognostic Factors for Disease Control and Survival Reminiscent of Oropharyngeal Cancers by Zhou, Margaret J., BS, Van Zante, Annemieke, MD, PhD, Lazar, Ann A., PhD, Groppo, Eli R., MD, Garsa, Adam A., MD, Ryan, William R., MD, El-Sayed, Ivan H., MD, Eisele, David W., MD, Yom, Sue S., MD, PhD, MAS

Get full text

Influence of respiratory motion management technique on radiation pneumonitis risk with robotic stereotactic body radiation therapy by Chapman, Christopher H., McGuinness, Christopher, Gottschalk, Alexander R., Yom, Sue S., Garsa, Adam A., Anwar, Mekhail, Braunstein, Steve E., Sudhyadhom, Atchar, Keall, Paul, Descovich, Martina

“…Purpose/Objectives For lung stereotactic body radiation therapy (SBRT), real‐time tumor tracking (RTT) allows for less radiation to normal lung compared to the…”
Get full text

Pyrosequencing of clinically relevant polymorphisms by Marsh, Sharon, King, Cristi R, Garsa, Adam A, McLeod, Howard L

“…The data generated from the Human Genome Project has led to an explosion of technology for low-, medium-, and high-throughput genotyping methods…”
Get more information